Name (Synonyms) | Correlation | |
---|---|---|
drug1393 | Immunoglubulins Wiki | 1.00 |
drug1823 | NO-Immunosuppressive Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D003141 | Communicable Diseases NIH | 0.08 |
D007239 | Infection NIH | 0.05 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
SAM-COVID is a retrospective cohort study that aims to determine the impact of immunosuppressive drugs and immunoglubulins in the outcome of patients with COVID-19.
Description: Days until invasive mechanical ventilation or death, whatever happened first.
Measure: Invasive ventilation or death Time: Up to 21 daysDescription: Days until mechanical ventilation
Measure: Ventilation Time: Up to 21 daysDescription: Days until death
Measure: Death Time: Up to 21 daysDescription: Proportion of patients developing secondary infections
Measure: Secondary infections Time: Up to 21 daysDescription: Proportion of patients with digestive tract hemorrhage
Measure: Digestive tract hemorrhage Time: Up to 21 daysDescription: Proportion of patients with imnprovement in 2 or more points in 7-point scale by WHO
Measure: Change in 7 points scale Time: Day 21